Eaton BR, Morton JA, Pickles M, White KE. A new antibody, anti-Yta, characterizing a blood-group antigen of high incidence. Br J Haematol 1956;2:333–41.10.1111/j.1365-2141.1956.tb06707.x13383099Search in Google Scholar
Race RR, Sanger R. Blood groups in man. 4th ed. Oxford, England: Blackwell Scientific Publications, 1962:320–1.Search in Google Scholar
Bergvalds H, Stock A, McClure PD. A further example of anti-Yta. Vox Sang 1965;10:627–30.10.1111/j.1423-0410.1965.tb01417.x5864819Search in Google Scholar
Dobbs JV, Prutting DL, Adebahr ME, Allen FH Jr, Alter AA. Clinical experience with three examples of anti-Yta. Vox Sang 1968;15:216–21.10.1111/j.1423-0410.1968.tb01752.x5683382Search in Google Scholar
Allen FH Jr, Milkovich L, Corcoran PA. A pedigree showing that Yta is not in the Lutheran blood-group system. Vox Sang 1963;8:376–7.10.1111/j.1423-0410.1963.tb05249.xSearch in Google Scholar
Giles CM, Metaxas MN. Identification of the predicted blood group antibody anti-Ytb. Nature 1964;202:1122–3.10.1038/2021122a014207215Search in Google Scholar
Giles CM, Metaxas-Bühler M, Romanski Y, Metaxas MN. Studies on the Yt blood group system. Vox Sang 1967;13: 171–80.10.1111/j.1423-0410.1967.tb03946.x6035447Search in Google Scholar
Ikin EW, Giles CM, Plaut G. A second example of anti-Ytb. Vox Sang 1965;10:212–13.10.1111/j.1423-0410.1965.tb04340.x14339230Search in Google Scholar
Wurzel HA, Haesler W Jr. Another example of anti-Ytb. Vox Sang 1968;14:460–1.Search in Google Scholar
Garratty G, Dzik W, Issitt PD, Lublin DM, Reid ME, Zelinski T. Terminology for blood group antigens and genes—historical origins and guidelines in the new millennium. Transfusion 2000;40:477–89.10.1046/j.1537-2995.2000.40040477.x10773062Search in Google Scholar
Reid ME, Lomas-Francis C. The blood group antigen factsbook. 2nd ed. San Diego, CA: Academic Press, 2004:332–7.10.1016/B978-012586585-2/50014-7Search in Google Scholar
Schenkel-Brunner H. Human blood groups. Chemical and biochemical basis of antigen specificity. 2nd ed. New York, NY: Springer, 2000:553–5.Search in Google Scholar
Daniels G. Human blood groups. 2nd ed. Malden, MA: Blackwell Science, 2002:369–73.10.1002/9780470987018Search in Google Scholar
Daniels DL, Fletcher A, Garratty G, Henry S, et al. Blood group terminology 2004: from the International Society of Blood Transfusion committee on terminology for red cell surface antigens. Vox Sang 2004;87:304–16.10.1111/j.1423-0410.2004.00564.xSearch in Google Scholar
Garratty G, Dzik W, Issitt PD, Lublin DM, Reid ME, Zelinski T. Terminology for blood group antigens and genes—historical origins and guidelines in the new millennium. Transfusion 2000;40:477–89.10.1046/j.1537-2995.2000.40040477.xSearch in Google Scholar
Shows TB, McAlpine PJ, Boucheix C, et al. Guidelines for human gene nomenclature. An international system for human gene nomenclature (ISGN, 1987). Cytogenet Cell Genet 1987; 46:11–28.Search in Google Scholar
Levene C, Cohen T, Manny N, Bar-Shany S, Moulds JJ. Yt (Cartwright) blood groups among Israeli Jews. Transfusion 1985;25:180.10.1046/j.1537-2995.1985.25285169220.xSearch in Google Scholar
Levene C, Asher O, Shinar E, Yahalom V. Rare blood donors: a personal approach. Immunohematology 2006;22:64–8.10.21307/immunohematology-2019-348Search in Google Scholar
Levene C, Bar-Shany S, Manny N, Moulds JJ, Cohen T. The Yt blood groups in Israeli Jews, Arabs, and Druse. Transfusion 1987;27:471–4.10.1046/j.1537-2995.1987.27688071697.xSearch in Google Scholar
Wurzel HA, Haesler WE. The Yt blood groups in American Negroes. Vox Sang 1968;15:304–5.10.1111/j.1423-0410.1968.tb01765.xSearch in Google Scholar
Lewis M, Kaita H, Phillips S, et al. The Yt blood group system (ISBT No. 011). Genetic studies. Vox Sang 1987;53:52–6.Search in Google Scholar
Rao N, Whitsett CF, Oxendine SM, Telen MJ. Human erythrocyte acetylcholinesterase bears the Yta blood group antigen and is reduced or absent in the Yt(a–b–) phenotype. Blood 1993; 81:815–19.10.1182/blood.V81.3.815.815Search in Google Scholar
Issitt PD. Applied blood group serology. 3rd ed. Miami, FL: Montgomery Scientific Publications, 1995:387–8.Search in Google Scholar
Coghlan G, Kaita H, Belcher E, Phillips S, Lewis M. Evidence for genetic linkage between the KEL and YT blood group loci. Vox Sang 1989;57:88–9.10.1111/j.1423-0410.1989.tb04991.xSearch in Google Scholar
Zelinski T, White L, Coghlan G, Phillips S. Assignment of the YT blood group locus to chromosome 7q. Genomics 1991; 11:165–7.10.1016/0888-7543(91)90113-SSearch in Google Scholar
Zelinski T, Kaita H, Lewis M, et al. The Colton blood group locus: a linkage analysis. Transfusion 1988;28:435–8.10.1046/j.1537-2995.1988.28588337331.x3166547Search in Google Scholar
Zelinski T, Kaita H, Gilson T, Coghlan G, Phillipps S, Lewis M. Linkage between the Colton blood group locus and ASSP11 on chromosome 7. Genomics 1990;6:623–5.10.1016/0888-7543(90)90496-HSearch in Google Scholar
Zelinski T, Coghlan G, Myal Y, et al. Genetic linkage between the Kell blood group system and prolactin-inducible protein loci: provisional assignment of KEL to chromosome 7. Ann Hum Genet 1991;55:137–40.10.1111/j.1469-1809.1991.tb00406.xSearch in Google Scholar
Getman DK, Eubanks JH, Camp S, Evans GA, Taylor P. The human gene encoding acetylcholinesterase is located on the long arm of chromosome 7. Am J Hum Genet 1992;51:170–7.Search in Google Scholar
Massoulie J, Toutant JP. Vertebrate cholinesterase: structure and types of interaction. In: Whittaker VP, ed. Handbook of experimental pharmacology, vol 86. Berlin, Germany: Springer, 1988:167–224.Search in Google Scholar
Taylor P. The cholinesterases. J Biol Chem 1991; 266:4025–8.10.1016/S0021-9258(20)64277-6Search in Google Scholar
Lawson AA, Barr RD. Acetylcholinesterase in red blood cells. Am J Hematol 1987;26:101–12.10.1002/ajh.28302601143307392Search in Google Scholar
Spring FA, Gardner B, Anstee DJ. Evidence that the antigens of the Yt blood group system are located on human erythrocyte acetylcholinesterase. Blood 1992;80:2136–41.10.1182/blood.V80.8.2136.2136Search in Google Scholar
Bartels CF, Zelinski T, Lockridge O. Mutation at codon 322 in the human acetylcholinesterase (ACHE) gene accounts for YT blood group polymorphism. Am J Hum Genet 1993;52: 928–36.Search in Google Scholar
Branch DR, Meunsch HA, Sy Siok Hian AL, Petz LD. Disulfide bonds are a requirement for Kell and Cartwright (Yta ) blood group antigen integrity. Brit J Haematol 1983;54:573–8.10.1111/j.1365-2141.1983.tb02136.x6871108Search in Google Scholar
Avent ND. Human erythrocyte antigen expression: its molecular bases. Br J Biomed Sci 1997;54:16–37.Search in Google Scholar
Anstee DJ. Blood group-active surface molecules of the human red blood cell. Vox Sang 1990;58:1–20.10.1111/j.1423-0410.1990.tb02049.x2180209Search in Google Scholar
Vengelen-Tyler V, Morel PA. Serologic and IgG subclass characterization of Cartwright (Yt) and Gerbich (Ge) antibodies. Transfusion 1983;23:114–16.10.1046/j.1537-2995.1983.23283172845.x6836689Search in Google Scholar
Levene C, Harel N. 2-Aminoethylisothiouronium-treated red cells and the Cartwright (Yta ) antigen. Transfusion 1984; 24: 541.10.1046/j.1537-2995.1984.24685066825.x6506190Search in Google Scholar
Telen MJ, Rosse WF, Parker CJ, Moulds MK, Moulds JJ. Evidence that several high-frequency human blood group antigens reside on phosphatidylinositol-linked erythrocyte membrane proteins. Blood 1990;75:1404–7.10.1182/blood.V75.7.1404.1404Search in Google Scholar
Roberts WL, Myher JJ, Kuksis A, Low MG, Rosenberry TL. Lipid analysis of the glycoinositol phospholipid membrane anchor of human erythrocyte acetylcholinesterase. Palmitoylation of inositol results in resistance to phosphatidylinositol-specific phospholipase C. J Biol Chem 1988;263:18766–75.10.1016/S0021-9258(18)37349-6Search in Google Scholar
Drew SI, Carter BM, Terasaki PI, et al. Cell surface antigens detected on mature and leukemic granulocyte populations by cytotoxicity testing. Tissue Antigens 1978;12:75–86.10.1111/j.1399-0039.1978.tb01302.x100897Search in Google Scholar
Pierce SR. A review of erythrocyte antigens shared with leukocytes. In: Bell CA, ed. A seminar on antigens on blood cells and body fluids. Washington, DC: AABB Press, 1980: 50–96.Search in Google Scholar
Dunstan RA. Status of major red cell group antigens on neutrophils, lymphocytes and monocytes. Br J Haematol 1986;62;301–9.10.1111/j.1365-2141.1986.tb02933.x3511947Search in Google Scholar
Nance SJ, Arndt P, Garratty G. Predicting the clinical significance of red cell alloantibodies using a monocyte monolayer assay. Transfusion 1987;27:449–52.10.1046/j.1537-2995.1987.27688071692.x3686653Search in Google Scholar
Arndt PA, Garratty G. A retrospective analysis of the value of monocyte monolayer assay results for predicting the clinical significance of blood group alloantibodies. Transfusion 2004; 44:1273–81.10.1111/j.1537-2995.2004.03427.x15318848Search in Google Scholar
Bettigole R, Harris JP, Tegoli J, Issitt PD. Rapid in vivo destruction of Yt(a+) red cells in a patient with anti-Yt. Vox Sang 1968;14:143–6.10.1159/000464675Search in Google Scholar
Göbel U, Drescher KH, Pöttgen W, Lehr HJ. A second example of anti-Yta with rapid in vivo destruction of Yt(a+) red cells. Vox Sang 1974;27:171–5.Search in Google Scholar
Ballas SK, Sherwood WC. Rapid in vivo destruction of Yt(a+) erythrocytes in a recipient with anti-Yta. Transfusion 1977;17:65–6.10.1046/j.1537-2995.1977.17177128889.x841677Search in Google Scholar
Davey RJ, Simpkins SS. 51 Chromium survival of Yt(a+) red cells as a determinant of the in vivo significance of anti-Yta. Transfusion 1981;21:702–5.10.1046/j.1537-2995.1981.21682085759.x7314218Search in Google Scholar
Silvergleid AJ, Wells RF, Hafleigh EB, Korn G, Kellner JJ, Grumet FC. Compatibility test using 51 chromium-labeled red blood cells in crossmatch positive patients. Transfusion 1978;18:8–14.10.1046/j.1537-2995.1978.18178118571.x625785Search in Google Scholar
AuBuchon JP, Brightman A, Anderson HJ, Kim B. An example of anti-Yta demonstrating a change in its clinical significance. Vox Sang 1988;55:171–5.Search in Google Scholar
Mazzi G, Raineri A, Santarossa L, De Roia D, Orazi BM. Presence of anti-Yta antibody in a Yt(a+) patient. Vox Sang 1994 66:130–2.10.1111/j.1423-0410.1994.tb00294.x8184594Search in Google Scholar
Mohandas K, Spivack M, Delehanty CL. Management of patients with anti-Cartwright (Yta ). Transfusion 1985;25: 382–4.10.1046/j.1537-2995.1985.25485273822.x4024238Search in Google Scholar
Levy GJ, Selset D, McQuiston D, Nance SJ, Garratty G, Smith LE, Goldfinger D. Clinical significance of anti-Ytb. Report of a case using a 51 chromium red cell survival study. Transfusion 1988;28:265–7.10.1046/j.1537-2995.1988.28388219157.x3285526Search in Google Scholar
Baldwin ML, Ness PM, Barrasso C, et al. In vivo studies of the long-term 51 Cr red cell survival of serologically incompatible red cell units. Transfusion 1985;25:34–8.10.1046/j.1537-2995.1985.25185116499.x3969699Search in Google Scholar
